198 related articles for article (PubMed ID: 19038916)
1. Impact of a better adherence to antihypertensive agents on cerebrovascular disease for primary prevention.
Kettani FZ; Dragomir A; Côté R; Roy L; Bérard A; Blais L; Lalonde L; Moreau P; Perreault S
Stroke; 2009 Jan; 40(1):213-20. PubMed ID: 19038916
[TBL] [Abstract][Full Text] [Related]
2. Adherence level of antihypertensive agents in coronary artery disease.
Perreault S; Dragomir A; Roy L; White M; Blais L; Lalonde L; Bérard A
Br J Clin Pharmacol; 2010 Jan; 69(1):74-84. PubMed ID: 20078615
[TBL] [Abstract][Full Text] [Related]
3. Impact of adherence to antihypertensive agents on clinical outcomes and hospitalization costs.
Dragomir A; Côté R; Roy L; Blais L; Lalonde L; Bérard A; Perreault S
Med Care; 2010 May; 48(5):418-25. PubMed ID: 20393367
[TBL] [Abstract][Full Text] [Related]
4. Better adherence to antihypertensive agents and risk reduction of chronic heart failure.
Perreault S; Dragomir A; White M; Lalonde L; Blais L; Bérard A
J Intern Med; 2009 Aug; 266(2):207 - 18. PubMed ID: 19623691
[TBL] [Abstract][Full Text] [Related]
5. Adherence to antihypertensive agents after ischemic stroke and risk of cardiovascular outcomes.
Perreault S; Yu AY; Côté R; Dragomir A; White-Guay B; Dumas S
Neurology; 2012 Nov; 79(20):2037-43. PubMed ID: 23115211
[TBL] [Abstract][Full Text] [Related]
6. Effect of statin adherence on cerebrovascular disease in primary prevention.
Perreault S; Ellia L; Dragomir A; Côté R; Blais L; Bérard A; Lalonde L
Am J Med; 2009 Jul; 122(7):647-55. PubMed ID: 19559167
[TBL] [Abstract][Full Text] [Related]
7. Persistence with treatment in newly treated middle-aged patients with essential hypertension.
Perreault S; Lamarre D; Blais L; Dragomir A; Berbiche D; Lalonde L; Laurier C; St-Maurice F; Collin J
Ann Pharmacother; 2005 Sep; 39(9):1401-8. PubMed ID: 16076920
[TBL] [Abstract][Full Text] [Related]
8. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients.
Mazzaglia G; Ambrosioni E; Alacqua M; Filippi A; Sessa E; Immordino V; Borghi C; Brignoli O; Caputi AP; Cricelli C; Mantovani LG
Circulation; 2009 Oct; 120(16):1598-605. PubMed ID: 19805653
[TBL] [Abstract][Full Text] [Related]
9. Relationship between adherence level to statins, clinical issues and health-care costs in real-life clinical setting.
Dragomir A; Côté R; White M; Lalonde L; Blais L; Bérard A; Perreault S
Value Health; 2010; 13(1):87-94. PubMed ID: 19695008
[TBL] [Abstract][Full Text] [Related]
10. Impact of adherence to statins on coronary artery disease in primary prevention.
Bouchard MH; Dragomir A; Blais L; Bérard A; Pilon D; Perreault S
Br J Clin Pharmacol; 2007 Jun; 63(6):698-708. PubMed ID: 17214831
[TBL] [Abstract][Full Text] [Related]
11. Comparison of persistence rates with angiotensin-converting enzyme inhibitors used in secondary and primary prevention of cardiovascular disease.
Gogovor A; Dragomir A; Savoie M; Perreault S
Value Health; 2007; 10(5):431-41. PubMed ID: 17888108
[TBL] [Abstract][Full Text] [Related]
12. Impact of better adherence to statin agents in the primary prevention of coronary artery disease.
Perreault S; Dragomir A; Blais L; Bérard A; Lalonde L; White M; Pilon D
Eur J Clin Pharmacol; 2009 Oct; 65(10):1013-24. PubMed ID: 19529927
[TBL] [Abstract][Full Text] [Related]
13. Health inequalities associated with neighbourhood deprivation in the Quebec population with hypertension in primary prevention of cardiovascular disease.
Vanasse A; Courteau J; Asghari S; Leroux D; Cloutier L
Chronic Dis Inj Can; 2014 Nov; 34(4):181-94. PubMed ID: 25408177
[TBL] [Abstract][Full Text] [Related]
14. [Adherence to antihypertensive and lipid-lowering medications: a problem of public health, not yet resolved].
Grosso G; Raciti T; Marventano S; Romeo I; Mistretta A
Ann Ig; 2011; 23(2):173-84. PubMed ID: 21770233
[TBL] [Abstract][Full Text] [Related]
15. First-year treatment adherence among outpatients initiating antihypertensive medication in Korea: results of a retrospective claims review.
Sung SK; Lee SG; Lee KS; Kim DS; Kim KH; Kim KY
Clin Ther; 2009 Jun; 31(6):1309-20. PubMed ID: 19695396
[TBL] [Abstract][Full Text] [Related]
16. Short-term adherence to beta-blocker therapy among ethnic Chinese patients with hypertension: a cohort study.
Wong MC; Jiang JY; Griffiths SM
Clin Ther; 2009 Oct; 31(10):2170-7; discussion 2150-1. PubMed ID: 19922888
[TBL] [Abstract][Full Text] [Related]
17. Predictors of adherence with antihypertensive and lipid-lowering therapy.
Chapman RH; Benner JS; Petrilla AA; Tierce JC; Collins SR; Battleman DS; Schwartz JS
Arch Intern Med; 2005 May; 165(10):1147-52. PubMed ID: 15911728
[TBL] [Abstract][Full Text] [Related]
18. Medication adherence before an increase in antihypertensive therapy: a cohort study using pharmacy claims data.
Grant RW; Singer DE; Meigs JB
Clin Ther; 2005 Jun; 27(6):773-81. PubMed ID: 16117984
[TBL] [Abstract][Full Text] [Related]
19. Adherence to antihypertensive agents improves risk reduction of end-stage renal disease.
Roy L; White-Guay B; Dorais M; Dragomir A; Lessard M; Perreault S
Kidney Int; 2013 Sep; 84(3):570-7. PubMed ID: 23698228
[TBL] [Abstract][Full Text] [Related]
20. [Diminished glomerular filtration rate as a marker of chronic kidney disease in hypertensive patients].
Grabysa R; Cholewa M
Pol Merkur Lekarski; 2008 Jun; 24(144):487-91. PubMed ID: 18702327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
